Tag: NASDAQ: AQST

Business

Aquestive Therapeutics Inc (NASDAQ: AQST) Resubmits Novel Drug Submission for Libervant™ Buccal Film

Aquestive Therapeutics Inc (NASDAQ: AQST) announced today the resubmission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Libervant™ Buccal Film. The new submission was to administer attack bunches to answer the FDA’s September 25, 2020, Complete Response Letter. The proposal comprised added algebraically […]